HUTCHMED (China) Ltd
LSE:HCM
HUTCHMED (China) Ltd
Net Income (Common)
HUTCHMED (China) Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
HUTCHMED (China) Ltd
LSE:HCM
|
Net Income (Common)
$100.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
33%
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Net Income (Common)
HK$1.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
21%
|
CAGR 10-Years
34%
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Net Income (Common)
¥2.7B
|
CAGR 3-Years
57%
|
CAGR 5-Years
32%
|
CAGR 10-Years
53%
|
S
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Net Income (Common)
¥2.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
11%
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Net Income (Common)
¥1.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
21%
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Net Income (Common)
HK$3.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
See Also
What is HUTCHMED (China) Ltd's Net Income (Common)?
Net Income (Common)
100.8m
USD
Based on the financial report for Dec 31, 2023, HUTCHMED (China) Ltd's Net Income (Common) amounts to 100.8m USD.
What is HUTCHMED (China) Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
33%